
Rabicip 20 Tablet
Marketer
Cipla Ltd
Salt Composition
Rabeprazole (20mg)
Overview Rabicip 20 Tablet
Acid-reducing medication, Rabicip 20 Tablet, alleviates stomach acid production. It treats acid-related gastrointestinal disorders including acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, offering symptomatic relief and facilitating healing. Administer one tablet hourly before meals, ideally in the morning. Dosage is condition-specific and response-dependent; maintain consistent daily timing as directed. Continue treatment as prescribed even with rapid symptom resolution. Dietary modifications—smaller, more frequent meals; avoiding caffeine, spicy, and fatty foods—can supplement therapy. Common, usually mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, and stomach ache. Report persistent or bothersome effects to your physician. Prolonged use (over a year), particularly at higher doses, may elevate fracture risk. Discuss bone loss prevention strategies, such as calcium and vitamin D supplementation, with your doctor. Hypomagnesemia (low magnesium) has been observed after three months or more of use, potentially causing fatigue, confusion, dizziness, muscle spasms, and arrhythmia; your physician may monitor your magnesium levels. Rabicip 20 Tablet is contraindicated in individuals with severe hepatic impairment, those on HIV medications, those with prior allergic reactions to similar drugs, or pre-existing osteoporosis. Pregnant or lactating women should seek medical advice before use. Alcohol consumption should be avoided due to its acid-stimulating effect. Refrain from operating machinery if dizziness or drowsiness occurs.
Uses of Rabicip 20 Tablet
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Rabicip 20 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Rabicip 20 Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Rabicip 20 Tablet:
- Diarrhea
- Dizziness
- Flatulence
- Headache
- Nausea
- Sore throat
- Stomach pain
- Vomiting
How to use Rabicip 20 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rabicip 20 Tablets should be taken on an empty stomach.
How Rabicip 20 Tablet works:
Gastric acid secretion is diminished by the proton pump inhibitor (PPI) in Rabicip 20 Tablet, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Use of Rabicip 20 Tablet with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Rabicip 20 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against potential hazards before recommending its use. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Rabicip 20 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer via breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Rabicip 20 Tablet might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
For individuals with kidney impairment, Rabicip 20 Tablet is considered safe for administration. No alteration of the Rabicip 20 Tablet dosage is advised.
LiverSAFE IF PRESCRIBED
Patients with liver conditions can safely take Rabicip 20 Tablets without requiring a change in dosage.
What if you forget to take Rabicip 20 Tablet :
Should you forget a Rabicip 20 Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Rabicip 20 Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Behavioral Class | Gastric acid suppressants |
